These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17616687)

  • 41. Analyzing the G2/M checkpoint.
    Stark GR; Taylor WR
    Methods Mol Biol; 2004; 280():51-82. PubMed ID: 15187249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer.
    Young LC; Listgarten J; Trotter MJ; Andrew SE; Tron VA
    Br J Dermatol; 2008 Jan; 158(1):59-69. PubMed ID: 17970804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
    Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
    Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different S/M checkpoint responses of tumor and non tumor cell lines to DNA replication inhibition.
    Rodríguez-Bravo V; Guaita-Esteruelas S; Salvador N; Bachs O; Agell N
    Cancer Res; 2007 Dec; 67(24):11648-56. PubMed ID: 18089794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of Msh2 knockdown on methylating agent induced toxicity in DNA glycosylase deficient cells.
    Cooley N; Elder RH; Povey AC
    Toxicology; 2010 Jan; 268(1-2):111-7. PubMed ID: 20025921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint.
    Hawn MT; Umar A; Carethers JM; Marra G; Kunkel TA; Boland CR; Koi M
    Cancer Res; 1995 Sep; 55(17):3721-5. PubMed ID: 7641183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity.
    Wotring LL; Roti Roti JL
    Cancer Res; 1980 May; 40(5):1458-62. PubMed ID: 7370984
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA mismatch repair and the DNA damage response to ionizing radiation: making sense of apparently conflicting data.
    Martin LM; Marples B; Coffey M; Lawler M; Lynch TH; Hollywood D; Marignol L
    Cancer Treat Rev; 2010 Nov; 36(7):518-27. PubMed ID: 20413225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of internally nuclease-protected single-strand DNA oligonucleotides and silencing of the mismatch repair protein, MSH2, enhances the replication of corrected cells following gene editing.
    Papaioannou I; Disterer P; Owen JS
    J Gene Med; 2009 Mar; 11(3):267-74. PubMed ID: 19153972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [DNA damage induces BRCA1 distribution alteration in prostate cancer cell lines].
    Wang CY; Sun SK; Fu WJ; Song T; Cai W; Gao JP; Hong BF; Wang XX; Wang H
    Zhonghua Nan Ke Xue; 2008 Aug; 14(8):685-9. PubMed ID: 18817338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest.
    Yun J; Zhong Q; Kwak JY; Lee WH
    Oncogene; 2005 Jun; 24(25):4009-16. PubMed ID: 15782115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel role for DNA mismatch repair and the autophagic processing of chemotherapy drugs in human tumor cells.
    Zeng X; Kinsella TJ
    Autophagy; 2007; 3(4):368-70. PubMed ID: 17426439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The cell cycle and DNA mismatch repair.
    Schroering AG; Edelbrock MA; Richards TJ; Williams KJ
    Exp Cell Res; 2007 Jan; 313(2):292-304. PubMed ID: 17157834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity.
    Cloos J; Temmink O; Ceelen M; Snel MH; Leemans CR; Braakhuis BJ
    Environ Mol Mutagen; 2002; 40(2):79-84. PubMed ID: 12203399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
    Cortellino S; Turner D; Masciullo V; Schepis F; Albino D; Daniel R; Skalka AM; Meropol NJ; Alberti C; Larue L; Bellacosa A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15071-6. PubMed ID: 14614141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
    Schwartz EL; Blair OC; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of tumor suppressor p53 facilitates DNA repair but not UV-induced G2/M arrest or apoptosis in Chinese hamster ovary CHO-K1 cells.
    Chang YC; Liao CB; Hsieh PY; Liou ML; Liu YC
    J Cell Biochem; 2008 Feb; 103(2):528-37. PubMed ID: 17549699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines.
    Supiot S; Gouard S; Charrier J; Apostolidis C; Chatal JF; Barbet J; Davodeau F; Cherel M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7047s-7052s. PubMed ID: 16203801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint.
    Yamane K; Chen J; Kinsella TJ
    Cancer Res; 2003 Jun; 63(12):3049-53. PubMed ID: 12810625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis.
    Trenz K; Schütz P; Speit G
    Mutagenesis; 2005 Mar; 20(2):131-7. PubMed ID: 15784691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.